IL15 and graft versus host disease: In conjunction, administration of cytokines including IL-2 and IL-15 to promote NK cell proliferation in vivo can awaken alloreactive T cells, trigger the heightened production of pro-inflammatory cytokines (IFN-y and TNF-a), and promote GvHD.